ArticleSystematic reviews2026
Segmentation for pelvic malignancies in radiation oncology practice: a systematic review and meta-analysis protocol.
Article in Systematic reviews, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDeep learning (DL)-based artificial intelligence (AI) models, the fourth generation in autosegmentation, have been adopted both for commercial and research applications worldwide and have shown great promise as reliable and comprehensive resource strategies for radiotherapy workflows.
methodsA comprehensive search will be conducted on Medline (PubMed), Scopus, the Cochrane Library, EMBASE, and Web of Science between January 2004 and December 2025. We will conduct a title, abstract, and full-text screening of all studies as per the eligibility criteria. Two reviewers will be involved in screening studies, quality appraisal, and data extraction, and a third reviewer will be consulted to resolve conflicts. Based on data availability, the data will be synthesised via meta-analysis and narrative synthesis. The reporting will be performed using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, ensuring the reliability and validity of the results. DISCUSSION: The model's performance will be assessed using various quantitative indices, qualitative tools, timesavings, and dosimetry. This review will enable us to determine the accuracy of autosegmentation for targets and various pelvic organs, boosting clinicians' confidence in facilitating the clinical implementation of such tools in routine clinical practice. SYSTEMATIC REVIEW REGISTRATION: The protocol is prospectively registered on PROSPERO. The registration ID is CRD42024491066.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.